ALZN
Price
$2.34
Change
-$0.07 (-2.90%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
7.57M
SRPT
Price
$17.51
Change
+$0.12 (+0.69%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
1.82B
44 days until earnings call
Interact to see
Advertisement

ALZN vs SRPT

Header iconALZN vs SRPT Comparison
Open Charts ALZN vs SRPTBanner chart's image
Alzamend Neuro
Price$2.34
Change-$0.07 (-2.90%)
Volume$200
Capitalization7.57M
Sarepta Therapeutics
Price$17.51
Change+$0.12 (+0.69%)
Volume$79.32K
Capitalization1.82B
ALZN vs SRPT Comparison Chart in %
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. SRPT commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Buy and SRPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 15, 2025
Stock price -- (ALZN: $2.41 vs. SRPT: $17.39)
Brand notoriety: ALZN: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 31% vs. SRPT: 25%
Market capitalization -- ALZN: $7.57M vs. SRPT: $1.82B
ALZN [@Biotechnology] is valued at $7.57M. SRPT’s [@Biotechnology] market capitalization is $1.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, ALZN is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 4 TA indicator(s) are bullish while SRPT’s TA Score has 3 bullish TA indicator(s).

  • ALZN’s TA Score: 4 bullish, 2 bearish.
  • SRPT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALZN is a better buy in the short-term than SRPT.

Price Growth

ALZN (@Biotechnology) experienced а +3.88% price change this week, while SRPT (@Biotechnology) price change was -7.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.53%. For the same industry, the average monthly price growth was +7.37%, and the average quarterly price growth was +34.29%.

Reported Earning Dates

SRPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+3.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($1.82B) has a higher market cap than ALZN($7.57M). ALZN YTD gains are higher at: -76.916 vs. SRPT (-85.698). SRPT has higher annual earnings (EBITDA): 36.1M vs. ALZN (-4.16M). SRPT has more cash in the bank: 800M vs. ALZN (3.36M). ALZN has less debt than SRPT: ALZN (301K) vs SRPT (1.35B). SRPT has higher revenues than ALZN: SRPT (2.48B) vs ALZN (0).
ALZNSRPTALZN / SRPT
Capitalization7.57M1.82B0%
EBITDA-4.16M36.1M-12%
Gain YTD-76.916-85.69890%
P/E RatioN/A27.21-
Revenue02.48B-
Total Cash3.36M800M0%
Total Debt301K1.35B0%
FUNDAMENTALS RATINGS
SRPT: Fundamental Ratings
SRPT
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
16

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNSRPT
RSI
ODDS (%)
Bullish Trend 6 days ago
67%
Bearish Trend 4 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
70%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 14 days ago
78%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
80%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNSS2.200.04
+1.85%
Genasys
PMCB1.040.01
+0.97%
PharmaCyte Biotech
TWLO102.33-0.23
-0.22%
Twilio
GLAD23.51-0.09
-0.38%
Gladstone Capital Corp
CPRX19.97-0.28
-1.38%
Catalyst Pharmaceuticals

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
+0.42%
SRPT - ALZN
49%
Loosely correlated
-2.90%
VRAX - ALZN
46%
Loosely correlated
+2.76%
ASBP - ALZN
43%
Loosely correlated
-5.85%
SNSE - ALZN
41%
Loosely correlated
-3.96%
BPMUF - ALZN
36%
Loosely correlated
N/A
More